Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Temporary PSA rises and repeat prostate biopsies after brachytherapy.

S Smathers1, K Wallner, J Sprouse

  • 1Department of Radiation Oncology, University of Washington, Seattle, Washington, USA.

International Journal of Radiation Oncology, Biology, Physics
|August 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.

Public health action·2018
Same author

Uptake of Neonicotinoid Insecticides by Water-Foraging Honey Bees (Hymenoptera: Apidae) Through Guttation Fluid of Winter Oilseed Rape.

Journal of economic entomology·2015
Same author

Lack of microsatellite instability in human prostate-cancer.

International journal of oncology·2011
Same author

Linezolid in the treatment of multidrug-resistant tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2009
Same author

NAN-190 potentiates the circadian response to light and speeds re-entrainment to advanced light cycles.

Neuroscience·2008
Same author

The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.

The Journal of pathology·2008

Temporary PSA rises after brachytherapy can be misleading. Even with positive biopsies, some patients achieve long-term control, avoiding unnecessary prostatectomy.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate brachytherapy is a common treatment for localized prostate cancer.
  • Post-treatment monitoring often involves Prostate-Specific Antigen (PSA) levels and biopsies.
  • Temporary PSA fluctuations can complicate interpretation of treatment efficacy.

Observation:

  • Four patients experienced temporary PSA increases 1-2 years post-brachytherapy.
  • Despite persistently elevated PSA and positive repeat biopsies, these patients showed PSA decline.
  • Salvage prostatectomy was recommended for these patients due to biopsy results.

Findings:

  • Histologic evidence of persistent cancer was noted in 3 of 4 patients.
  • All 4 patients demonstrated a significant PSA decrease, indicating successful long-term cancer control.

Related Experiment Videos

  • Surgery would likely have been inappropriate for these individuals.

    • Implications:

    • Clinicians must recognize temporary PSA rises and positive rebiopsies as potentially misleading.
    • Awareness can prevent unnecessary salvage therapies and guide appropriate patient management.
    • This highlights the need for careful interpretation of post-brachytherapy monitoring data.